Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2008 Jul 9;231(3):364–373. doi: 10.1016/j.taap.2008.05.022

Fig. 8. mRNA expression of Nrf2 target genes in kidneys from wild-type and Nrf2-null mice 6 h after FeNTA (5 mg/kg) treatment.

Fig. 8

Total RNA was isolated from control and FeNTA-treated mouse kidneys and analyzed by the bDNA assay as described in MATERIALS AND METHODS. Data are presented as mean (percent of WT control) ± S.E.M. (each group, n = 4 or 5 animals). WT-SAL, vehicle-treated wild-type mice; Nrf2-null SAL, vehicle-treated null mice; WT-FeNTA, FeNTA-treated wild-type mice; Nrf2-null FeNTA, FeNTA-treated null mice. Asterisks (*) represent a statistically significant difference (p < 0.05) from vehicle-treated mice of the same genotype; daggers (†) represent a statistically significant difference (p < 0.05) from WT FeNTA group.